Octane Medical acquires B. Braun’s global orthobiologics business
We innovate game changing medical technologies.
We advance innovations into production within market-specific ventures.
We build partnerships for global commercialization.
Our body’s natural processes and materials are highly efficient at repairing damage and restoring normal function. Octane innovations work at the cellular level to harness and accelerate these inherent healing abilities, with the goal of achieving sustained therapeutic benefits that surpass conventional therapies.
It’s regenerative medicine at its best. Together with our partners, we’re working at the highest levels of creativity to develop, manufacture and commercialize the most advanced bioprocesses, biomaterials and bioreactors. Our goal: to make regenerative medicine the new standard of care.
January 2, 2025
TETEC AG’S CDMO business is now Octane CDMO, a global operation with automation expertise
Kingston, Ontario, January 2, 2024 – The Octane Medical Group is pleased to announce that the contract development and manufacturing arm of its German subsidiary TETEC AG is now Octane CDMO, an expanded operation with the know-how, years of experience, technology, systems and international network to drive complex, personalized cell therapies from concept to commercialization.
June 5, 2024
Octane Medical acquires B. Braun’s global orthobiologics business
Kingston, Ontario, Canada / Melsungen, Germany, June 5th, 2024 – Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition, consisting of the two companies TETEC AG in Germany and Aesculap Biologics, LLC. in the United States, establishes Octane as an international leader in regenerative medicine.
March 2, 2022
Octane HyperPEEK® offers breakthrough biocomposite for enhanced bone regeneration
Kingston, Ontario, June 2, 2022 – Octane Exo Inc., an Octane Medical Group venture, has achieved a breakthrough in medical implant technology with Octane HyperPEEK, an advanced biocomposite proven to enhance bone regeneration with the goal of enhanced integration and stability.
December 15, 2020
Octane Completes Major Expansion of State-of-the-Art Facility in Kingston, Ontario
Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada. The 40,000-square-foot building, which Octane purchased in 2011, houses the company's head office and features regulated biolabs for biomaterial and biologics discovery programs including cell therapy research and development, a ...
